Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honggui Xu

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
BMC Cancer|January 9, 2024
Prognostic significance of multiparametric flow cytometry minimal residual disease at two time points after induction in pediatric acute myeloid leukemiaYongzhi Zheng, Lili Pan, Jian Li, et al.
Cancer Medicine|May 3, 2023
Clinical characteristics and prognosis analysis of patients with de novo ASXL1-mutated AML treated with the C-HUNAN-AML-15 protocol: A multicenter study by the South China Pediatric AML Collaborative GroupMinhui Zeng, Keke Chen, Xin Tian, et al.
Frontiers in Oncology|September 30, 2021
High <i>EVI1</i> Expression Predicts Adverse Outcomes in Children With <i>De Novo</i> Acute Myeloid LeukemiaYongzhi Zheng, Yan Huang, Shaohua Le, et al.
Annals of Hematology|June 10, 2026
KIT and FLT3-ITD mutations do not predict outcomes in pediatric core-binding factor acute myeloid leukemia: findings from the C-HUANAN-AML-15 multicenter cohort studyYongzhi Zheng, Lihua Yu, Shaohua Le, et al.
Stem Cell Research & Therapy|March 19, 2026
The effect of cladribine-containing conditioning regimen on the efficacy and safety of allogeneic hematopoietic stem cell transplantation for children with acute lymphoblastic leukemiaXinyu Li, Keyue Hu, Shaofen Lin, et al.
BMC Medical Genomics|May 29, 2024
The potential role of RNA sequencing in diagnosing unexplained insensitivity to conventional chemotherapy in pediatric patients with B-cell acute lymphoblastic leukemiaXinyu Li, Zaoli Huang, Liwen Zhu, et al.
Hemoglobin|December 11, 2025
Identification of a Patient with Transfusion-Dependent β-Thalassemia Caused by Compound Heterozygous Mutations of <i>HBB</i>: C.84_85insC and Common Linked Intronic Variants in <i>HBB</i>Lang Qin, Xinyu Li, Yin Wang, et al.
Stem Cell Research & Therapy|December 21, 2024
A novel conditioning regimen with pre-transplantation immunosuppression reduces the complication rates in hematopoietic stem cell transplantation in transfusion-dependent β-thalassemiaHuaqing Yang, Xinyu Li, Liping Que, et al.
Hematology (Amsterdam, Netherlands)|May 5, 2025
A Chinese pediatric patient with thalassemia traits and compound heterozygous mutations in the <i>PIEZO1 g</i>ene suspected of having dehydrated hereditary stomatocytosisWeijie Chen, Xinyu Li, Huaqing Yang, et al.
Cancer Medicine|May 17, 2026
Integrated Molecular Risk Stratification and Measurable Residual Disease-Guided Consolidation Improve Outcomes in Pediatric Non-Down Syndrome Acute Megakaryoblastic LeukemiaChunxia Cai, Yiqiao Chen, Chunping Wu, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
BMC Cancer|January 9, 2024
Prognostic significance of multiparametric flow cytometry minimal residual disease at two time points after induction in pediatric acute myeloid leukemiaYongzhi Zheng, Lili Pan, Jian Li, et al.
Cancer Medicine|May 3, 2023
Clinical characteristics and prognosis analysis of patients with de novo ASXL1-mutated AML treated with the C-HUNAN-AML-15 protocol: A multicenter study by the South China Pediatric AML Collaborative GroupMinhui Zeng, Keke Chen, Xin Tian, et al.
Frontiers in Oncology|September 30, 2021
High <i>EVI1</i> Expression Predicts Adverse Outcomes in Children With <i>De Novo</i> Acute Myeloid LeukemiaYongzhi Zheng, Yan Huang, Shaohua Le, et al.
Annals of Hematology|June 10, 2026
KIT and FLT3-ITD mutations do not predict outcomes in pediatric core-binding factor acute myeloid leukemia: findings from the C-HUANAN-AML-15 multicenter cohort studyYongzhi Zheng, Lihua Yu, Shaohua Le, et al.
Stem Cell Research & Therapy|March 19, 2026
The effect of cladribine-containing conditioning regimen on the efficacy and safety of allogeneic hematopoietic stem cell transplantation for children with acute lymphoblastic leukemiaXinyu Li, Keyue Hu, Shaofen Lin, et al.
BMC Medical Genomics|May 29, 2024
The potential role of RNA sequencing in diagnosing unexplained insensitivity to conventional chemotherapy in pediatric patients with B-cell acute lymphoblastic leukemiaXinyu Li, Zaoli Huang, Liwen Zhu, et al.
Hemoglobin|December 11, 2025
Identification of a Patient with Transfusion-Dependent β-Thalassemia Caused by Compound Heterozygous Mutations of <i>HBB</i>: C.84_85insC and Common Linked Intronic Variants in <i>HBB</i>Lang Qin, Xinyu Li, Yin Wang, et al.
Stem Cell Research & Therapy|December 21, 2024
A novel conditioning regimen with pre-transplantation immunosuppression reduces the complication rates in hematopoietic stem cell transplantation in transfusion-dependent β-thalassemiaHuaqing Yang, Xinyu Li, Liping Que, et al.
Hematology (Amsterdam, Netherlands)|May 5, 2025
A Chinese pediatric patient with thalassemia traits and compound heterozygous mutations in the <i>PIEZO1 g</i>ene suspected of having dehydrated hereditary stomatocytosisWeijie Chen, Xinyu Li, Huaqing Yang, et al.
Cancer Medicine|May 17, 2026
Integrated Molecular Risk Stratification and Measurable Residual Disease-Guided Consolidation Improve Outcomes in Pediatric Non-Down Syndrome Acute Megakaryoblastic LeukemiaChunxia Cai, Yiqiao Chen, Chunping Wu, et al.
Pageof 3